KeyBanc Sees Injectable GLP-1s Driving Ongoing Demand for WST [Yahoo! Finance]
West Pharmaceutical Services, Inc. (WST)
Last west pharmaceutical services, inc. earnings: 4/23 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.westpharma.com
Company Research
Source: Yahoo! Finance
KeyBanc sees limited risk to oral weight loss drugs through 2030, even with the potential approval of an oral version of Wegovy. In a research note, the firm said oral GLP-1 adoption is likely to stay capped in both the near and longer term, despite new products entering the market. KeyBanc estimates the oral version of Wegovy would add only about 200 basis points to total GLP-1 market share by 2030. The firm also believes GLP-1 suppliers are taking a cautious view on market penetration. West Pharmaceutical Services, Inc. (NYSE:WST) and Stevanato Group have both pointed to assumptions that oral drugs could eventually account for 30% of the overall GLP-1 market. KeyBanc is more conservative and expects injectable formats to remain the primary growth driver as next-generation GLP-1s roll out. Under that scenario, both suppliers should continue to see volume ramp. Earlier in October, West Pharmaceutical Services, Inc. (NYSE:WST) raised its full-year profit forecast after reporting bet
Show less
Read more
Impact Snapshot
Event Time:
WST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WST alerts
High impacting West Pharmaceutical Services, Inc. news events
Weekly update
A roundup of the hottest topics
WST
News
- West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbViePR Newswire
- A Look At West Pharmaceutical Services (WST) Valuation After Recent Share Price Moves [Yahoo! Finance]Yahoo! Finance
- 2 Safe-and-Steady Stocks with Solid Fundamentals and 1 We Question [Yahoo! Finance]Yahoo! Finance
- West Pharmaceutical Services (NYSE:WST) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=WST&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall MarketBeat
- West to Participate in Upcoming Investor ConferencePR Newswire
WST
Earnings
- 10/23/25 - Beat
WST
Sec Filings
- 1/5/26 - Form 4
- 12/10/25 - Form 4
- 12/10/25 - Form 3
- WST's page on the SEC website